Monday, February 2, 2015

BUZZ-Roche's anti-PDL1 drug gets jump in lung cancer

… ;breakthrough therapy designation" in lung cancer from U.S. FDA, giving … Keytruda in lung cancer, while Bristol has had success in lung cancer survival study …

No comments:

Post a Comment